Federal Funding for Gender-Affirming Care for Low-Income Minors Restricted by Trump Administration

The Trump administration has finalized a rule prohibiting Medicaid and the Children's Health Insurance Program (CHIP) from funding puberty blockers, hormone therapy, and surgeries for gender dysphoria in minors. This decision, effective in October, will impact access to care for 35.5 million U.S. children covered by these programs. The policy shifts financial responsibility to states, families, and private insurance, significantly altering healthcare access for a specific demographic.